July 3, 2026 Regulatory
Elekta's Annual Report for 2025/26 available
June 17, 2026 Regulatory
Elekta presents financial targets and detailed outlook ahead of Capital Markets Day
June 12, 2026
Nomination Committee’s proposal for the Board of Directors prior to Elekta’s Annual General Meeting 2026
May 28, 2026 Regulatory
Year-end report May–April 2025/26
May 18, 2026
New research presented at ESTRO 2026 highlights advances in MR-guided radiotherapy
May 13, 2026
Invitation to the presentation of Elekta’s fiscal year 2025/26
April 17, 2026
Invitation to Elekta's Capital Markets Day on June 17, 2026
March 5, 2026 Regulatory
Third quarter, November–January 2025/26
February 25, 2026 Regulatory
Change in Elekta’s Nomination Committee for the Annual General Meeting 2026
February 19, 2026
Invitation to Elekta’s Q3 2025/26 call at 9:00 a.m. CET, March 5
January 30, 2026
Elekta presents Strategic Update: growth, innovation, and operations
January 23, 2026
Elekta appoints Tomas Eliasson as Vice Chair of the Board
January 16, 2026 Regulatory
Elekta receives FDA 510(k) clearance for Elekta Evo linear accelerator
January 12, 2026
Invitation to Elekta's Strategic Update event on January 30